Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based on Proteomics

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) accounts for 85% of pancreatic carcinoma cases. Patients with PDAC have a poor prognosis. The lack of reliable prognostic biomarkers makes treatment challenging for patients with PDAC. Using a bioinformatics database, we sought to identify prognost...

Descripción completa

Detalles Bibliográficos
Autores principales: Kou, Yan-qi, Yang, Yu-ping, Pan, Zhao-jie, Du, Shen-shen, Yuan, Wei-nan, He, Kun, Nie, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2023
Materias:
Database Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015732/
https://www.ncbi.nlm.nih.gov/pubmed/36905103
http://dx.doi.org/10.12659/MSM.938785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015732/
https://www.ncbi.nlm.nih.gov/pubmed/36905103
http://dx.doi.org/10.12659/MSM.938785

Ejemplares similares